Antoon H van Lierop
Overview
Explore the profile of Antoon H van Lierop including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Claessen K, Pelsma I, Kroon H, van Lierop A, Pereira A, Biermasz N, et al.
Endocrine
. 2021 Aug;
75(1):228-238.
PMID: 34448099
Purpose: Bone health is compromised in acromegaly resulting in vertebral fractures (VFs), regardless of biochemical remission. Sclerostin is a negative inhibitor of bone formation and is associated with increased fracture...
2.
van Lierop A, Bisschop P, Boelen A, van Eeden S, Engelman A, Nieveen van Dijkum E, et al.
J Surg Case Rep
. 2019 Dec;
2019(12):rjz346.
PMID: 31832136
In this case report, we describe a 40-year-old patient with a large grade 2 pancreatic neuroendocrine tumour (pNET) with spleen metastasis. Albeit radical resection, he developed liver metastasis after 2 ...
3.
van Lierop A, Appelman-Dijkstra N, Papapoulos S
Bone
. 2016 Oct;
96:51-62.
PMID: 27742500
Sclerosteosis and van Buchem disease are two rare bone sclerosing dysplasias caused by genetic defects in the synthesis of sclerostin. In this article we review the demographic, clinical, biochemical, radiological,...
4.
van Lierop A, Hamdy N, van Egmond M, Bakker E, Dikkers F, Papapoulos S
J Bone Miner Res
. 2012 Oct;
28(4):848-54.
PMID: 23074140
Van Buchem disease (VBD) is a rare bone sclerosing dysplasia caused by the lack of a regulatory element of the SOST gene, which encodes for sclerostin, an osteocyte-derived negative regulator...
5.
Yavropoulou M, van Lierop A, Hamdy N, Rizzoli R, Papapoulos S
Bone
. 2012 May;
51(1):153-7.
PMID: 22579776
Evidence has been accumulating for the role of osteocytes as key players in the regulation of bone remodeling. One of the main products of these cells, sclerostin, inhibits bone formation...
6.
Witteveen J, van Lierop A, Papapoulos S, Hamdy N
Eur J Endocrinol
. 2011 Oct;
166(1):55-60.
PMID: 21984611
Introduction: Fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) are major players in the bone-parathyroid-kidney axis controlling phosphate homeostasis. In patients with primary hyperparathyroidism (PHPT), data on the relationship...
7.
van Lierop A, Hamdy N, Hamersma H, van Bezooijen R, Power J, Loveridge N, et al.
J Bone Miner Res
. 2011 Jul;
26(12):2804-11.
PMID: 21786318
Sclerosteosis is a rare bone sclerosing dysplasia, caused by loss-of-function mutations in the SOST gene, encoding sclerostin, a negative regulator of bone formation. The purpose of this study was to...